Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Prevalent mutations in the FLG gene underlie the common skin disorder ichthyosis vulgaris and are significant risk factors for atopic dermatitis (eczema). The recent publication of a strategy to sequence this difficult gene identifies a spectrum of both prevalent and rare mutations that collectively have a significant impact on susceptibility to atopic disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/sj.jid.5700876 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies.
J Invest Dermatol
September 2025
Department of Dermatology, School of Medicine, University of California San Diego, San Diego, California, USA. Electronic address:
Real-World Efficacy and Safety of Dupilumab for Atopic Dermatitis in the Israeli Population.
Int J Dermatol
July 2025
Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Teledermatological services at a Swiss university hospital - evaluation of patient benefits and economic impact .
J Dermatolog Treat
December 2025
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Objectives: The aim of this study is to evaluate the potential of online consultation services in a Swiss dermatological clinic as a tool for triage, focusing on time savings, patient satisfaction, and cost-effectiveness.
Methods: Over a period of 30 months, data were generated from a publicly available store-and-forward teledermatological platform (www.derma2go.
Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors.
Int J Dermatol
September 2025
Pfizer S.L.U, Madrid, Spain.
Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine administration. This document aims to provide dermatologists and other healthcare practitioners with comprehensive practical vaccination recommendations for adults and adolescent patients with atopic dermatitis who are receiving or are about to receive treatment with JAK inhibitors.
View Article and Find Full Text PDFInterpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis.
J Eur Acad Dermatol Venereol
September 2025
Department of Dermatology, Xuancheng Tongren Hospital, Xuancheng, Anhui, China.